Sat, Feb 28, 2015, 12:44 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

  • afriendofthedevilsafriendofmine afriendofthedevilsafriendofmine Sep 14, 2013 2:14 PM Flag

    Motley video

    He says he likes the chances of our heart failure drug but would buy the safer AMGN over CYTK. With one company's market cap more than 360 times that of the other, I find it hard to imagine that is the correct play on omecamtiv mecarbil, or this technology in general. If one is risk adverse, buy a smaller stake.

    If one is interested in playing AMGN's pipeline (I am not) then buy AMGN. But the video is about heart failure treatment.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
7.71-0.25(-3.14%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.